We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPSN icon
5651
CALL
LivePerson
LPSN
$32.3M
$185K ﹤0.01%
+333
New +$191K
CLM icon
5652
Cornerstone Strategic Value Fund
CLM
$2.25B
$184K ﹤0.01%
16,668
-2,037
-11% -$22.4K
DAVA icon
5653
Endava
DAVA
$156M
$184K ﹤0.01%
3,947
+3,389
+607% +$146K
EVC icon
5654
Entravision Communication
EVC
$1.1B
$184K ﹤0.01%
70,041
+20,673
+42% +$56.5K
NQP
5655
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
$184K ﹤0.01%
12,980
+40
+0.3% +$565
PBFS icon
5656
Pioneer Bancorp
PBFS
$434M
$184K ﹤0.01%
12,045
+1,657
+16% +$22.4K
UMDD icon
5657
ProShares UltraPro MidCap400
UMDD
$35M
$184K ﹤0.01%
7,460
-945
-11% -$20.8K
LTM
5658
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$184K ﹤0.01%
18,063
+6,934
+62% +$77.5K
VIE
5659
DELISTED
Viela Bio, Inc. Common Stock
VIE
$183K ﹤0.01%
+6,734
New +$170K
AKRX
5660
DELISTED
Akorn Inc
AKRX
$183K ﹤0.01%
122,272
-83,785
-41% -$316K
HFFG icon
5661
HF Foods Group
HFFG
$83.4M
$182K ﹤0.01%
9,309
+2,537
+37% +$50.4K
GLNG icon
5662
Golar LNG
GLNG
$5.13B
$181K ﹤0.01%
12,770
-4,588
-26% -$62.2K
KLXE icon
5663
KLX Energy Services
KLXE
$42.3M
$181K ﹤0.01%
5,625
+2,254
+67% +$83.8K
PROV icon
5664
Provident Financial
PROV
$112M
$180K ﹤0.01%
8,216
+2,441
+42% +$51.8K
SRT
5665
DELISTED
Startek Inc.
SRT
$180K ﹤0.01%
22,496
+9,747
+76% +$71.1K
ALCO icon
5666
Alico
ALCO
$283M
$179K ﹤0.01%
4,985
+1,897
+61% +$63.8K
CSGS
5667
DELISTED
CSG Systems International
CSGS
$179K ﹤0.01%
3,454
-9,754
-74% -$526K
SGC icon
5668
Superior Group of Companies
SGC
$225M
$179K ﹤0.01%
13,184
+4,639
+54% +$67K
CSTL icon
5669
Castle Biosciences
CSTL
$979M
$178K ﹤0.01%
5,193
+2,383
+85% +$58.3K
DPST icon
5670
Direxion Daily Regional Banks Bull 3X ETF
DPST
$391M
$178K ﹤0.01%
+171
New +$155K
FYLD icon
5671
Cambria Foreign Shareholder Yield ETF
FYLD
$720M
$178K ﹤0.01%
7,301
+690
+10% +$16.2K
MBIO icon
5672
Mustang Bio
MBIO
$4.55M
$178K ﹤0.01%
58
+29
+100% +$66.4K
TBT icon
5673
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$305M
$178K ﹤0.01%
6,693
+6,631
+10,695% +$169K
JNCE
5674
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$178K ﹤0.01%
20,395
+7,915
+63% +$42.8K
GEN
5675
DELISTED
Genesis Healthcare, Inc.
GEN
$178K ﹤0.01%
108,476
+40,973
+61% +$61.5K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.